These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 11490828

  • 1. Improvement of the prognosis of gastric cancer with extensive serosal invasion using left upper abdominal evisceration.
    Isozaki H, Tanaka N, Fujii K, Tanigawa N, Okajima K.
    Hepatogastroenterology; 2001; 48(40):1179-82. PubMed ID: 11490828
    [Abstract] [Full Text] [Related]

  • 2. Postoperative results of left upper abdominal evisceration for advanced gastric cancer.
    Yonemura Y, Kawamura T, Nojima N, Bandou E, Keizou T, Fujita H, Michiwa Y, Fujimura T, Fushida S, Ajisaka H, Miwa K.
    Hepatogastroenterology; 2000; 47(32):571-4. PubMed ID: 10791241
    [Abstract] [Full Text] [Related]

  • 3. [Left upper abdominal evisceration for advanced gastric cancer].
    Oyama S, Nakajima T, Ota K, Ishihara S, Wakabayashi K, Nishi M.
    Gan To Kagaku Ryoho; 1994 Aug; 21(11):1781-6. PubMed ID: 8080296
    [Abstract] [Full Text] [Related]

  • 4. Prognostic significance of macroscopic serosal invasion in advanced gastric cancer.
    Yasuda K, Shiraishi N, Inomata M, Shiroshita H, Izumi K, Kitano S.
    Hepatogastroenterology; 2007 Aug; 54(79):2028-31. PubMed ID: 18251153
    [Abstract] [Full Text] [Related]

  • 5. Serosal invasion as the single prognostic indicator in stage IIIA (T3N1M0) gastric cancer.
    Abe S, Shiraishi M, Nagaoka S, Yoshimura H, Dhar DK, Nakamura T.
    Surgery; 1991 May; 109(5):582-8. PubMed ID: 2020903
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Is bursectomy necessary for patients with gastric cancer invading the serosa?
    Yoshikawa T, Tsuburaya A, Kobayashi O, Sairenji M, Motohashi H, Hasegawa S, Ishiwa N, Morinaga S, Noguchi Y, Yamamoto Y, Matsumoto A.
    Hepatogastroenterology; 2004 May; 51(59):1524-6. PubMed ID: 15362792
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Multivariate prognostic study on large gastric cancer.
    Shiraishi N, Sato K, Yasuda K, Inomata M, Kitano S.
    J Surg Oncol; 2007 Jul 01; 96(1):14-8. PubMed ID: 17582596
    [Abstract] [Full Text] [Related]

  • 10. Therapeutic strategy for scirrhous type gastric cancer.
    Kunisaki C, Shimada H, Nomura M, Matsuda G, Otsuka Y, Ono H, Akiyama H.
    Hepatogastroenterology; 2005 Jul 01; 52(61):314-8. PubMed ID: 15783058
    [Abstract] [Full Text] [Related]

  • 11. Surgical treatment for advanced carcinoma of the gastric remnant.
    Isozaki H, Tanaka N, Fujii K, Nomura E, Tanigawa N.
    Hepatogastroenterology; 1998 Jul 01; 45(23):1896-900. PubMed ID: 9840172
    [Abstract] [Full Text] [Related]

  • 12. Prognostic impact of the width of subserosal invasion in gastric cancer invading the subserosal layer.
    Soga K, Ichikawa D, Yasukawa S, Kubota T, Kikuchi S, Fujiwara H, Okamoto K, Ochiai T, Sakakura C, Kokuba Y, Yanagisawa A, Otsuji E.
    Surgery; 2010 Feb 01; 147(2):197-203. PubMed ID: 19758672
    [Abstract] [Full Text] [Related]

  • 13. [Prognostic factors in gastric cancer with serosal invasion--importance of the extent of cancer infiltration in the subserosal layer].
    Habu H, Kando F, Saito N, Takeshita K, Sunagawa M, Endo M.
    Gan No Rinsho; 1989 May 01; 35(6):685-9. PubMed ID: 2724547
    [Abstract] [Full Text] [Related]

  • 14. Prognostic studies on gastric cancer with concomitant liver metastases.
    Fujisaki S, Tomita R, Nezu T, Kimizuka K, Park E, Fukuzawa M.
    Hepatogastroenterology; 2001 May 01; 48(39):892-4. PubMed ID: 11462950
    [Abstract] [Full Text] [Related]

  • 15. [Results of left upper abdominal evisceration (LUAE) in diffuse infiltrating carcinoma of the stomach].
    Ohta K, Nishi M, Nakajima T.
    Gan To Kagaku Ryoho; 1988 Apr 01; 15(4 Pt 2-2):1249-55. PubMed ID: 3382198
    [Abstract] [Full Text] [Related]

  • 16. Modified radical lymphadenectomy without splenectomy in patients with proximal gastric cancer: comparison with standard D2 lymphadenectomy for distal gastric cancer.
    Cheong O, Kim BS, Yook JH, Oh ST, Park YK, Ryu SY.
    J Surg Oncol; 2008 Dec 01; 98(7):500-4. PubMed ID: 18770520
    [Abstract] [Full Text] [Related]

  • 17. Intraoperative chemohyperthermic peritoneal perfusion as an adjuvant to gastric cancer: final results of a randomized controlled study.
    Yonemura Y, de Aretxabala X, Fujimura T, Fushida S, Katayama K, Bandou E, Sugiyama K, Kawamura T, Kinoshita K, Endou Y, Sasaki T.
    Hepatogastroenterology; 2001 Dec 01; 48(42):1776-82. PubMed ID: 11813623
    [Abstract] [Full Text] [Related]

  • 18. A new surgical technique (left upper abdominal evisceration) for advanced carcinoma of the gastric stump.
    Yonemura Y, Sugiyama K, Fujimura T, Kamata T, Sawa T, Takashima T, Ninomiya I, Fonseca L, Tsugawa K, Matsumoto H.
    Hepatogastroenterology; 1994 Apr 01; 41(2):130-3. PubMed ID: 8056399
    [Abstract] [Full Text] [Related]

  • 19. Neoadjuvant chemotherapy with CDDP and 5-fluorouracil for gastric cancer with serosal invasion.
    Takiguchi N, Nunomura M, Koda K, Oda K, Suzuki H, Miyazaki M.
    Oncol Rep; 2003 Apr 01; 10(2):433-8. PubMed ID: 12579285
    [Abstract] [Full Text] [Related]

  • 20. Postoperative morbidity/mortality and survival rates after total gastrectomy, with splenectomy/pancreaticosplenectomy for patients with advanced gastric cancer.
    Yamamoto M, Baba H, Kakeji Y, Endo K, Ikeda Y, Toh Y, Kohnoe S, Okamura T, Maehara Y.
    Hepatogastroenterology; 2004 Apr 01; 51(55):298-302. PubMed ID: 15011889
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.